MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$83,784K
Net loss
-$83,784K
Net loss before
income taxes
-$83,784K
Interest income and other
income, net
$4,367K
Manufacture And Supply
Revenue
$40,225K
License And Royalty
Revenue
$3,519K
Co Development And
Research Fees
$1,279K
Loss from operations
-$71,051K
Interest expense
$11,120K
Interest expense related
to royalty...
$5,737K
Revenues
$44,545K
Interest expense related
to the sale of...
$243K
Proprietary Product Revenue
-$478K
Total costs and
expenses
$115,596K
Selling, general and
administrative
$79,849K
Manufacture and supply
$18,555K
Research and development
$17,192K
Back
Back
Income Statement
source: myfinsight.com
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)